Attached files
| file | filename |
|---|---|
| S-1 - S-1 - Arno Therapeutics, Inc | v450204_s1.htm |
| EX-5.1 - EXHIBIT 5.1 - Arno Therapeutics, Inc | v450204_ex5-1.htm |
Exhibit 23.1
Consent of Independent Registered Public Accounting Firm
We consent to the use in this Registration Statement of Arno Therapeutics, Inc. on Form S-1 of our report dated March 30, 2016, which included an emphasis of matter paragraph regarding the Company’s ability to continue as a going concern, on the financial statements of Arno Therapeutics, Inc. and to the reference to us under the heading “Experts” in the prospectus.
/s/ Crowe Horwath LLP
New York, New York
October 12, 2016